AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionTrilogy Capital Inc.
Latest Disclosed Ownership21,426 shares
Latest Disclosed Value $ 4,659,904
Trilogy Capital Inc. reports 2.05% increase in ownership of 4AB / AbbVie Inc.

On April 21, 2026 - Trilogy Capital Inc. filed a 13F-HR form disclosing ownership of 21,426 shares of AbbVie Inc. (BG:4AB) valued at $4,659,904 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 20,996 shares of AbbVie Inc.. This represents a change in shares of 2.05% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ABBVIE COM 00287Y109 21,426 430 2.05 4,660 -2.88 0.2017
2026-01-22 2025-12-31 13F ABBVIE COM 00287Y109 20,996 -241 -1.13 4,797 -2.44 0.2144
2025-10-24 2025-09-30 13F ABBVIE COM 00287Y109 21,237 -363 -1.68 4,917 22.65 0.2272
2025-07-18 2025-06-30 13F ABBVIE COM 00287Y109 21,600 -494 -2.24 4,009 -13.39 0.1950
2025-05-07 2025-03-31 13F ABBVIE COM 00287Y109 22,094 6,270 39.62 4,629 64.67 0.2428
2025-01-27 2024-12-31 13F ABBVIE COM 00287Y109 15,824 11,281 248.32 2,812 213.38 0.1446
2024-10-21 2024-09-30 13F ABBVIE COM 00287Y109 4,543 -151 -3.22 897 11.43 0.0452
2024-07-23 2024-06-30 13F ABBVIE COM 00287Y109 4,694 -73 -1.53 805 -7.26 0.0437
2024-04-17 2024-03-31 13F ABBVIE COM 00287Y109 4,767 -14,901 -75.76 868 -71.52 0.0499
2024-01-12 2023-12-31 13F ABBVIE COM 00287Y109 19,668 -194 -0.98 3,048 2.97 0.1886
2023-10-16 2023-09-30 13F ABBVIE COM 00287Y109 19,862 117 0.59 2,961 4.30 0.2004
2023-07-24 2023-06-30 13F ABBVIE COM 00287Y109 19,745 761 4.01 2,838 -6.18 0.1809
2023-04-17 2023-03-31 13F ABBVIE COM 00287Y109 18,984 3,058 19.20 3,025 17.57 0.2150
2023-02-09 2022-12-31 13F ABBVIE COM 00287Y109 15,926 2,289 16.79 2,574 40.60 0.1826
2022-10-21 2022-09-30 13F ABBVIE COM 00287Y109 13,637 1,618 13.46 1,830 -0.60 0.1640
2022-07-20 2022-06-30 13F ABBVIE COM 00287Y109 12,019 -460 -3.69 1,841 -9.00 0.1602
2022-04-08 2022-03-31 13F ABBVIE COM 00287Y109 12,479 1,890 17.85 2,023 41.07 0.1452
2022-01-18 2021-12-31 13F ABBVIE COM 00287Y109 10,589 453 4.47 1,434 31.20 0.1075
2021-10-15 2021-09-30 13F ABBVIE COM 00287Y109 10,136 29 0.29 1,093 -8.07 0.0832
2021-07-14 2021-06-30 13F ABBVIE COM 00287Y109 10,107 2,290 29.30 1,189 40.54 0.0875
2021-04-12 2021-03-31 13F ABBVIE COM 00287Y109 7,817 1,260 19.22 846 20.34 0.0647
2021-02-05 2020-12-31 13F ABBVIE COM 00287Y109 6,557 83 1.28 703 23.99 0.0575
2020-11-16 2020-09-30 13F ABBVIE COM 00287Y109 6,474 -360 -5.27 567 -16.62 0.0542
2020-07-22 2020-06-30 13F ABBVIE COM 00287Y109 6,834 -171 -2.44 680 14.67 0.0673
2020-04-28 2020-03-31 13F ABBVIE COM 00287Y109 7,005 -1,766 -20.13 593 -23.97 0.0656
2020-01-10 2019-12-31 13F ABBVIE COM 00287Y109 8,771 572 6.98 780 27.45 0.0765
2019-10-07 2019-09-30 13F ABBVIE COM 00287Y109 8,199 968 13.39 612 18.15 0.0652
2019-07-11 2019-06-30 13F ABBVIE COM 00287Y109 7,231 698 10.68 518 -1.52 0.0572
2019-04-17 2019-03-31 13F ABBVIE COM 00287Y109 6,533 6,533 526 0.0626
2019-01-15 2018-12-31 13F ABBVIE COM 00287Y109 0 -224 -100.00 0 -100.00
2018-10-31 2018-09-30 13F ABBVIE COM 00287Y109 224 1 0.45 21 0.00 0.0026
2018-08-17 2018-06-30 13F ABBVIE COM 00287Y109 223 -4 -1.76 21 0.00 0.0028
2018-05-24 2018-03-31 13F ABBVIE COM 00287Y109 227 -7,933 -97.22 21 -97.34 0.0030
2018-02-07 2017-12-31 13F ABBVIE COM 00287Y109 8,160 8,160 789 0.1283
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.